Tarsus Pharmaceuticals (TARS) Receivables - Net (2021 - 2026)
Tarsus Pharmaceuticals' Receivables - Net was $96.03 million in Q2 2026, up 64.6% from $58.33 million a year earlier but down 4.3% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Receivables - Net (2021 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Tarsus Pharmaceuticals came in at $85.06 million, up 81.9% from FY2024.
- In earlier years, Receivables - Net was $46.76 million in FY2024 (+181.3%) and $16.62 million in FY2023.
- Quarterly Receivables - Net has moved between $17,000 (Q1 2022) and $100.34 million (Q1 2026) over five years.
- Compared with a year earlier, Receivables - Net has increased for eight straight quarters, with growth averaging 148.5% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q3 2024 (growth of 443.8%); the worst was Q1 2022 (a decline of 99.9%).
- Per Business Quant data, TARS's Receivables - Net in the three quarters before Q2 2026 was $100.34 million (Q1 2026), $85.06 million (Q4 2025) and $72.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Tarsus Pharmaceuticals | 3.32 Bn | 2.27 Bn | 161.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.03 Mn |
| Mar 31, 2026 | 100.34 Mn |
| Dec 31, 2025 | 85.06 Mn |
| Sep 30, 2025 | 72.62 Mn |
| Jun 30, 2025 | 58.33 Mn |
| Mar 31, 2025 | 62.43 Mn |
| Dec 31, 2024 | 46.76 Mn |
| Sep 30, 2024 | 29.16 Mn |
| Jun 30, 2024 | 29.53 Mn |
| Mar 31, 2024 | 29.89 Mn |
| Dec 31, 2023 | 16.62 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Jun 30, 2021 | 20.00 Mn |
| Mar 31, 2021 | 25.00 Mn |
API Access
Tarsus Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();